Abstract
Anti-C1q has been associated with systemic lupus erythematosus (SLE) and lupus nephritis in previous studies. We studied anti-C1q specificity for SLE (vs rheumatic disease controls) and the association with SLE manifestations in an international multicenter study.
Original language | English |
---|---|
Pages (from-to) | 42-49 |
Journal | Lupus |
Volume | 24 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2015 |
Subject classification (UKÄ)
- Microbiology in the medical area
- Immunology in the medical area
- Rheumatology and Autoimmunity